Individuals' experiences of the integration of substance use/addiction and HIV/AIDS services in community settings: a qualitative systematic review protocol.
Community Health Services
/ organization & administration
Delivery of Health Care, Integrated
/ statistics & numerical data
Female
HIV Infections
/ drug therapy
Health Personnel
/ psychology
Health Services Accessibility
Humans
Male
New York
Patient Acceptance of Health Care
Substance-Related Disorders
/ complications
Systematic Reviews as Topic
Journal
JBI evidence synthesis
ISSN: 2689-8381
Titre abrégé: JBI Evid Synth
Pays: United States
ID NLM: 101764819
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
pubmed:
3
8
2020
medline:
20
4
2021
entrez:
3
8
2020
Statut:
ppublish
Résumé
The objectives of this systematic review are: i) to identify, appraise, and synthesize the best available evidence on individuals' experiences of the integration of substance use/addiction and HIV/AIDS services in community settings, and ii) to identify barriers to and facilitators of the integration of the services. The integration of drug use treatment and HIV services has shown to improve HIV prevention, decrease HIV infection and progression, while improving access to social and support services among substance users. Combined pharmacological and behavioral drug use treatments have been proven to diminish behaviors that increase HIV risk, decrease incidence of the disease, and improve adherence to antiretroviral therapy among individuals who use drugs and are HIV-positive. The populations of interest in this review include patients who have experienced integrated substance use/addiction and HIV services, as well as health care professionals and policy makers who have been involved in developing or implementing integrated substance use/addiction and HIV/AIDS services. Eligible studies will focus on the views, attitudes, understandings, and perceptions of patients, health care professionals, and policy makers resulting from experience in developing or implementing strategies that have or could inform the integration of substance use/addiction and HIV/AIDS services in community settings. Searches will be conducted in MEDLINE, Embase, PsycINFO, and CINHAL. The search for unpublished studies will include OpenGrey, Grey Matters, New York Academy of Medicine's Grey Literature Report, ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform. Selected studies will be critically appraised by two independent reviewers for methodological quality. Data will be extracted and then synthesized following the JBI meta-aggregative approach. PROSPERO CRD42020185858.
Identifiants
pubmed: 32740031
pii: 02174543-202012000-00013
doi: 10.11124/JBISRIR-D-19-00391
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2687-2693Informations de copyright
Copyright © 2020 JBI.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
UNAIDS. Miles to go: closing gaps, breaking barriers, fighting injustices. Global AIDS Report, 2018 [internet]. 2018 [cited 2019 Nov 25]. Available from: https://www.unaids.org/en/resources/documents/2018/global-aids-update.
Erickson A, Becker M, Shaw S, Kasper K, Keynan Y. Substance use and its impact on care outcomes among HIV-infected individuals in Manitoba. AIDS Care 2015; 27 (9):1168–1173.
Ayon S, Ndimbii J, Jeneby F, Abdulrahman T, Mlewa O, Wang B, et al. Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers. AIDS Care 2018; 30 (4):480–487.
Yang LH, Wong LY, Grivel MM, Hasin DS. Stigma and substance use disorders: an international phenomenon. Curr Opin Psychiatry 2017; 30 (5):378–388.
Laws HB, Ellerbeck NE, Rodrigues AS, Simmons JA, Ansell EB. Social rejection and alcohol use in daily life. Alcohol Clin Exp Res 2017; 41 (4):820–827.
Sohler NL, Wong MD, Cunningham WE, Cabral H, Drainoni ML, Cunningham CO. Type and pattern of illicit drug use and access to health care services for HIV-infected people. AIDS Patient Care STDS 2007; 21 (1):68–76.
Vagenas P, Azar MM, Copenhaver MM, Springer SA, Molina PE, Altice FL. The impact of alcohol use and related disorders on the HIV continuum of care: a systematic review: alcohol and the HIV continuum of care. Curr HIV/AIDS Rep 2015; 12 (4):421–436.
Lancaster KE, Hetrick A, Jaquet A, Adedimeji A, Atwoli L, Colby DJ, et al. Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities. J Virus Erad 2018; 4 (2):26–32.
Woody GE, Bruce D, Korthuis PT, Chhatre S, Poole S, Hillhouse M, et al. HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial. J Acquir Immune Defic Syndr 2014; 66 (3):288–293.
Culbert GJ, Waluyo A, Wang M, Putri TA, Bazazi AR, Altice FL. Adherence to antiretroviral therapy among incarcerated persons with HIV: associations with methadone and perceived safety. AIDS Behav 2019; 23 (8):2048–2058.
Rhodes T, Guise A, Ndimbii J, Strathdee S, Ngugi E, Platt L, et al. Is the promise of methadone Kenya's solution to managing HIV and addiction? A mixed-method mathematical modelling and qualitative study. BMJ Open 2015; 5 (3):1–12.
Kresina TF, Eldred L, Bruce RD, Francis H. Integration of pharmacotherapy for opioid addiction into HIV primary care for HIV/hepatitis C virus-co-infected patients. AIDS 2005; 19 (3):221–226.
Collins AB, Parashar S, Hogg RS, Fernando S, Worthington C, McDougall P, et al. Integrated HIV care and service engagement among people living with HIV who use drugs in a setting with a community-wide treatment as prevention initiative: a qualitative study in Vancouver, Canada. J Int AIDS Soc 2017; 20 (1):1–10.
Haldane V, Cervero-Liceras F, Chuah FL, Ong SE, Murphy G, Sigfrid L, et al. Integrating HIV and substance use services: a systematic review. J Int AIDS Soc 2017; 20 (1):1–14.
Weiss L, Netherland J, Egan JE, Flanigan TP, Fiellin DA, Finkelstein R, et al. Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative. J Acquir Immune Defic Syndr 2011; 56 (1):68–75.
Cooke A, Saleem H, Hassan S, Mushi D, Mbwambo J, Lambdin B. Patient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention. Addict Sci Clin Pract 2019; 14 (1):1–8.
Pinto RM, Chen Y, Park SE. A client-centered relational framework on barriers to the integration of HIV and substance use services: a systematic review. Harm Reduct J 2019; 16 (1):1–12.
Guise A, Seguin M, Mburu G, McLean S, Grenfell P, Islam Z, et al. Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences. AIDS Care 2017; 29 (9):1119–1128.
Sarang A, Rhodes T, Sheon N. Systemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study. Health Policy Plan 2013; 28 (7):681–691.
Strauss SM, Mino M. Addressing the HIV-related needs of substance misusers in New York State: the benefits and barriers to implementing a “one-stop shopping” model. Subst Use Misuse 2011; 46 (2–3):171–180.
Magidson JF, Joska JA, Regenauer KS, Satinsky E, Andersen LS, Seitz-Brown CJ, et al. “Someone who is in this thing that I am suffering from”: the role of peers and other facilitators for task sharing substance use treatment in South African HIV care. Int J Drug Policy 2019; 70:61–69.
Lockwood C, Porrit K, Munn Z, Rittenmeyer L, Salmond S, Bjerrum M. Aromataris E, Munn Z, et al. Chapter 2: Systematic reviews of qualitative evidence. JBI, JBI Reviewer's Manual [internet]. Adelaide:2017.
Moher D, Liberati A, Tetzlaff J, Altman DG. the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6 (7):1–6.
Munn Z, Porritt K, Lockwood C, Aromataris E, Pearson A. Establishing confidence in the output of qualitative research synthesis: the ConQual approach. BMC Med Res Methodol 2014; 14 (108):1–7.